Lexogen GmbH
- Funded by Austrian Research Promotion Agency (FFG)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Austrian Research Promotion Agency (FFG)Principal Investigator
N/A
Research Location
AustriaLead Research Institution
Lexogen GmbHResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The company's platform technology is to be adapted so that real mass screening is made possible using Next Generation Sequencing (NGS). At the same time, the mutation rate of the virus should be able to be tracked, which is of great importance for future epidemic predictions and vaccine development, and enables a differentiation from other pathogens that cause colds.